101 related articles for article (PubMed ID: 25079203)
1. Bullous melanoma: a rare variant of melanoma causing practical problems in determination of tumor thickness.
Woltsche NM; Cota C; Fink-Puches R; Requena L; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):133-7. PubMed ID: 25079203
[TBL] [Abstract][Full Text] [Related]
2. Differences in tumor thickness between hematoxylin and eosin and Melan-A immunohistochemically stained primary cutaneous melanomas.
Drabeni M; Lopez-Vilaró L; Barranco C; Trevisan G; Gallardo F; Pujol RM
Am J Dermatopathol; 2013 Feb; 35(1):56-63. PubMed ID: 22688397
[TBL] [Abstract][Full Text] [Related]
3. Follicular malignant melanoma: primary follicular or folliculotropic?
Machan S; El Shabrawi-Caelen L; Nikolay E; Kerl H; Requena L; Cerroni L
Am J Dermatopathol; 2015 Jan; 37(1):15-9. PubMed ID: 24614208
[TBL] [Abstract][Full Text] [Related]
4. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
5. Reticulin and NM23 staining in the interpretation of lymph nodal nevus rests.
Kanner WA; Barry CI; Smart CN; Frishberg DP; Binder SW; Wick MR
Am J Dermatopathol; 2013 Jun; 35(4):452-7. PubMed ID: 23694823
[TBL] [Abstract][Full Text] [Related]
6. Acantholytic-like malignant melanoma: an unusual morphologic variant.
Aneiros-Fernández J; Arias-Santiago S; Diaz-Recuero JL; O'valle Ravassa F; Nogales Fernández F; Aneiros Cachaza J
Am J Dermatopathol; 2010 Jun; 32(4):364-6. PubMed ID: 20216200
[TBL] [Abstract][Full Text] [Related]
7. Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of "melanotic schwannoma".
Torres-Mora J; Dry S; Li X; Binder S; Amin M; Folpe AL
Am J Surg Pathol; 2014 Jan; 38(1):94-105. PubMed ID: 24145644
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic role of galectin 3 expression in cutaneous melanoma.
Abdou AG; Hammam MA; Farargy SE; Farag AG; El Shafey EN; Farouk S; Elnaidany NF
Am J Dermatopathol; 2010 Dec; 32(8):809-14. PubMed ID: 20885286
[TBL] [Abstract][Full Text] [Related]
9. Features of small melanocytic lesions: does small mean benign? A clinical-dermoscopic study.
de Giorgi V; Savarese I; Rossari S; Gori A; Grazzini M; Crocetti E; Sara Longo A; Oranges T; Massi D
Melanoma Res; 2012 Jun; 22(3):252-6. PubMed ID: 22430838
[TBL] [Abstract][Full Text] [Related]
10. Pigment synthesizing melanoma (so-called animal type melanoma): a clinicopathological study of 14 cases of a poorly known distinctive variant of melanoma.
Antony FC; Sanclemente G; Shaikh H; Trelles AS; Calonje E
Histopathology; 2006 May; 48(6):754-62. PubMed ID: 16681693
[TBL] [Abstract][Full Text] [Related]
11. Pseudoglandular-type melanoma: a rare melanoma variant.
Tarlow MM; Nemlick AS; Rothenberg J; Schwartz RA
J Cutan Pathol; 2008 Jun; 35(6):588-90. PubMed ID: 18005169
[TBL] [Abstract][Full Text] [Related]
12. A colonization of basal cell carcinoma by malignant melanoma in situ resembling a malignant basomelanocytic tumor.
Goeser M; DiMaio DJ
Am J Dermatopathol; 2014 Nov; 36(11):e179-82. PubMed ID: 24752214
[TBL] [Abstract][Full Text] [Related]
13. Locally invasive dermal squamomelanocytic tumor with matrical differentiation: a peculiar case with review of the literature.
Rodić N; Taube JM; Manson P; Patel M; Patterson JW; Erdag G
Am J Dermatopathol; 2013 Jun; 35(4):e72-6. PubMed ID: 23694829
[TBL] [Abstract][Full Text] [Related]
14. Syringotropic Melanoma: A Diagnostic Challenge With Prognostic Implications.
Torre-Castro J; Haya-Martínez L; Moya-Martínez C; Núñez-Hipólito L; Mendoza-Cembranos MD; Sabaris MDCF; Eraña-Tomás I; Santonja C; Suárez Massa MD; Cerroni L; Requena L
Am J Dermatopathol; 2022 Jan; 44(1):33-36. PubMed ID: 33201009
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous melanocytic dysplasia and malignant melanoma. A critical review.
Kwittken J
J Med; 1991; 22(1):1-16. PubMed ID: 2072047
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
17. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
18. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
de la Fouchardière A; Vergier B
Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
[No Abstract] [Full Text] [Related]
19. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
[TBL] [Abstract][Full Text] [Related]
20. Predicting outcome in melanoma: where are we now?
Jennings L; Murphy GM
Br J Dermatol; 2009 Sep; 161(3):496-503. PubMed ID: 19624540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
